Forum Topic News
  • Conversation: FDA Approves Doptelet

    • May 22, 2018 12:55 PM BST
    • FDA Approves Doptelet

      The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the FDA for this use.




      “Patients with chronic liver disease who have low platelet counts and require a procedure are at increased risk of bleeding,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research. “Doptelet was demonstrated to safely increase the platelet count. This drug may decrease or eliminate the need for platelet transfusions, which are associated with risk of infection and other adverse reactions.”

       

      Read more: https://www.drugs.com/newdrugs/fda-approves-doptelet-avatrombopag-chronic-liver-patients-thrombocytopenia-undergoing-medical-4748.html

       

       


Add Reputation

Do you want to add reputation for this member by this post?

or cancel
‚Äč